Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.520
-0.100 (-2.76%)
Nov 12, 2024, 4:00 PM EST - Market closed
Mural Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -173.3 | -207.45 | -189.81 | -175.43 |
| Depreciation & Amortization | 3.14 | 2.57 | 1.54 | 1.47 |
| Stock-Based Compensation | 21.6 | 24.11 | 11.93 | 11.5 |
| Change in Accounts Payable | -9.41 | -18.25 | 8.39 | 5.52 |
| Change in Other Net Operating Assets | -4.1 | 4.77 | -0.64 | 0.27 |
| Operating Cash Flow | -159.89 | -194.25 | -168.59 | -156.67 |
| Capital Expenditures | -2.4 | -3.45 | -5.51 | -4.39 |
| Investing Cash Flow | -83.2 | -3.45 | -5.51 | -4.39 |
| Other Financing Activities | 366.65 | 468.81 | 174.1 | 161.05 |
| Financing Cash Flow | 366.65 | 468.81 | 174.1 | 161.05 |
| Net Cash Flow | 123.56 | 271.11 | - | - |
| Free Cash Flow | -162.29 | -197.7 | -174.1 | -161.05 |
| Free Cash Flow Per Share | -9.67 | -11.85 | -10.43 | - |
| Levered Free Cash Flow | -92.15 | -112.89 | -99.81 | - |
| Unlevered Free Cash Flow | -92.15 | -112.89 | -99.81 | - |
| Change in Net Working Capital | 7.28 | 14.47 | -7.81 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.